Harrow Strengthens Board Retention with Director Stock Awards
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Director Adrienne L. Graves of Harrow received a new equity compensation award on June 20, 2025, as reported in this Form 4 filing. The transaction details include:
- Awarded 7,339 Restricted Stock Units (RSUs) with $0 exercise price
- RSUs will vest fully on the one-year anniversary of the grant date
- Underlying shares cannot be delivered, transferred, or sold until termination of service
This grant appears to be part of the company's director compensation program, representing a standard compensatory award for board service. The filing was submitted by Andrew R. Boll as Attorney in Fact for the director on June 24, 2025, within the required reporting window. Ms. Graves holds these RSUs under direct ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Graves Adrienne L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | RSU | 7,339 | $0.00 | -- |
Holdings After Transaction:
RSU — 7,339 shares (Direct)
Footnotes (1)
- The Restricted Stock Units were received as a compensatory award for services rendered or to be rendered. Award of Restricted Stock Units vests in full on the one-year anniversary following the date of grant. The shares underlying such Restricted Stock Units will not be delivered to the Reporting Person and may not be transferred or sold until the termination of service.
FAQ
How many Restricted Stock Units (RSUs) did HROW director Adrienne Graves receive on June 20, 2025?
According to the Form 4 filing, HROW director Adrienne L. Graves received 7,339 Restricted Stock Units (RSUs) on June 20, 2025 as a compensatory award for services rendered or to be rendered.
What is the vesting schedule for HROW director Graves' RSU grant?
The RSU award vests in full on the one-year anniversary following the date of grant (June 20, 2025). The underlying shares cannot be delivered, transferred, or sold until the termination of Graves' service with HROW.
What is the exercise price of the RSUs granted to HROW's director Adrienne Graves?
The Restricted Stock Units were granted with an exercise price of $0, as shown in Table II of the Form 4 filing under the 'Conversion or Exercise Price of Derivative Security' column.
Who filed this Form 4 for HROW and what is their role?
The Form 4 was filed by Andrew R. Boll as Attorney in Fact for Adrienne L. Graves, who serves as a Director of Harrow, Inc. (HROW). The form was signed on June 24, 2025.